Could a higher dose of allergy medicine beat hives faster?

NCT ID NCT07236372

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares the standard dose of cetirizine (10 mg daily) to a higher dose (40 mg daily) for treating acute hives in adults. Researchers want to see if the higher dose relieves symptoms faster and reduces the need for steroid rescue medication. Participants take the assigned dose for 7 days and track their symptoms daily.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
cetirizine
What this could lead to
If it works, this could offer a more effective short-term treatment for acute hives and reduce the need for steroids.
What could go wrong
This is a small, early-stage trial with only 140 participants. Higher doses may cause more side effects like drowsiness, and results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE URTICARIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Phayao Hospital

    RECRUITING

    Phayao, Mueang, 56000, Thailand